March 2, 2025 · 8 min read

GLP-1: mechanism and evidence in metabolic research

How GLP-1 analogs act at the receptor level and what preclinical evidence exists on satiety and glycemic control.

Glucagon-like peptide 1 (GLP-1) is an incretin secreted by intestinal L cells in response to food intake.

Synthetic analogs — Semaglutide, Tirzepatide, Retatrutide — have become central research subjects due to their affinity for GLP-1R and their extended half-life.

In vitro studies show dose-dependent activation of the cAMP/PKA pathway in pancreatic cell lines, with effects on insulin secretion and gastric emptying in animal models.

Want to go deeper? Browse our catalog or contact us.

¿Te fue útil? Comparte este artículo: